sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiska medel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
ertapenem sun
sun pharmaceutical industries (europe) b.v. - ertapenemnatrium - bakterieinfektioner - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 och 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. hänsyn bör tas till officiella riktlinjer för lämplig användning av antibakteriella medel.
sunitinib teva 12,5 mg kapsel, hård
teva b.v. - sunitinib - kapsel, hård - 12,5 mg - sunitinib 12,5 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib teva 50 mg kapsel, hård
teva b.v. - sunitinib - kapsel, hård - 50 mg - sunitinib 50 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib sandoz 37,5 mg kapsel, hård
sandoz a/s - sunitinib - kapsel, hård - 37,5 mg - sunitinib 37,5 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne
sunitinib medical valley 37,5 mg kapsel, hård
medical valley invest ab - sunitinibmalat - kapsel, hård - 37,5 mg - sunitinibmalat 50,1 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne; tartrazin hjälpämne; para-orange hjälpämne
sunitinib zentiva 50 mg kapsel, hård
zentiva k.s. - sunitinib - kapsel, hård - 50 mg - sunitinib 50 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne
sunitinib glenmark 25 mg kapsel, hård
glenmark arzneimittel gmbh - sunitinib - kapsel, hård - 25 mg - sunitinib 25 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib avansor 50 mg kapsel, hård
avansor pharma oy - sunitinibmalat - kapsel, hård - 50 mg - sunitinibmalat 66,83 mg aktiv substans
sunitinib avansor 12,5 mg kapsel, hård
avansor pharma oy - sunitinibmalat - kapsel, hård - 12,5 mg - sunitinibmalat 16,71 mg aktiv substans